Efficacy and Safety of MT-5547 in Patients With Osteoarthritis Accompanied by Moderate to Severe Pain
Clinical trial NCT03245008 · COMPLETED
Trial details
- NCT number
- NCT03245008
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-08
- Primary completion
- 2019-12-14
- Enrollment
- 626
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.